News

February 25, 2021February 25, 2021

FDA Grants Fast Track Status to Celsion’s GEN-1 for Advanced Cancer

News

Celsion‘s immunotherapy candidate, GEN-1, has received fast track designation from the U.S. Food and Drug Administration (FDA) for advanced ovarian cancer. This designation helps speed the approval of potential medicines ... Read more

February 23, 2021February 23, 2021

She ROCKS Raises $100K to Support Early Work Into Stem Cell Therapy

News

She ROCKS, an organization working for earlier diagnosis and better treatments for ovarian cancer, raised $100,000 through recent virtual luncheon fundraisers to support ongoing research into a potential stem cell-based ... Read more

February 18, 2021February 18, 2021

Progesterone May Help Drive Spread of Ovarian Cancer, Preclinical Study Shows

News

The hormone progesterone helps to drive the development of metastatic ovarian cancer, and blocking progesterone signaling may be a useful strategy for preventing the cancer, a study in mice suggests. ... Read more

February 16, 2021February 16, 2021

InVivo Analytics Granted $1.7M to Advance Preclinical 3D Imaging

News

InVivo Analytics has received $1.7 million to develop and commercialize its next-generation fluorescence imaging device, called InVivoFLUOR, for 3D monitoring of immune cell migration in animal models of cancer, the ... Read more

February 11, 2021February 11, 2021

ENB-003 with Keytruda Shows Promise Against Advanced Solid Tumors

News

ENB Therapeutics’ lead novel anti-cancer therapy, ENB-003, was found to be safe and showed promising anti-tumor activity, when given in combination with Keytruda (pembrolizumab), to adults with different types of ... Read more

February 9, 2021February 9, 2021

€15M EU Project Seeks to Improve Personalized Medicine Options

News

The European Union is providing nearly €15 million ($18.1 million) over five years to improve personalized medicine options for people with drug-resistant high-grade serous ovarian cancer. The DECIDER project, funded ... Read more

February 4, 2021February 8, 2021

Early Trial Starts Testing Recommended STRO-002 Dose for Advanced Cancer

News

Note: This story was updated Feb. 8, 2021, to note that the ovarian cancer expansion group will include 40 participants, not 20. Sutro Biopharma‘s Phase 1 clinical trial has begun ... Read more

February 2, 2021February 2, 2021

Blocking Glutamine Metabolism May Help Combat OCCC Tumors

News

Ovarian cancer cells harboring mutations in the ARID1A tumor suppressor gene tend to use the amino acid glutamine as a source of energy more often, making the cells more vulnerable ... Read more

January 28, 2021January 28, 2021

BioVaxys Advances Plans to Bring Vaccine to Clinic

News

BioVaxys is planning to request that its investigational vaccine for ovarian cancer, BVX-0918A, be approved for compassionate use in people with advanced ovarian cancer in Europe. The company also plans ... Read more

January 26, 2021

Combining Imaging Methods May Reduce Need for Tumor Biopsies

News

Combining two imaging methods can provide a more accurate sampling of single tumors — like those found in ovarian cancer — thus allowing doctors to capture the diverse cancer cells ... Read more